Google Chrome
Safari
Firefox
Edge
News / Jan 16, 2025
Hovione strengthens its global position as a top employer
The certification is granted to Hovione's four manufacturing sites for the third consecutive year.
Search
Press Release / Jan 16, 2025
Hovione strengthens its global position as a top employer for the third consecutive year
Hovione has once again solidified its position as a top employer.
News / Dec 19, 2024
ViSync® Technologies appoints Elsa Abranches as Chief Scientific Officer
ViSync® Technologies, a joint venture between Hovione and iBET is proud to announce the appointment of Elsa Abranches as its Chief Scientific Officer (CSO).
Press Clipping / Nov 25, 2024
Pharma company Hovione to double capacity at Cork site as part multi-million euro investment
Irish Examiner, 25 November 2024
Press Clipping / Nov 25, 2024
Pharma company announces expansion of Cork facility to create more than 20 new jobs
EchoLive, 25 November 2024
Press Release / Nov 26, 2024
Hovione Expands Global Spray Drying Capacity with Significant Investment in the USA and Ireland
Hovione has completed significant expansions at its facilities in New Jersey, USA, and Cork, Ireland.
Article / Sep 24, 2024
Formulating Inhaled Medicines
Excipient and delivery device selection play crucial roles in the formulation of inhaled drugs.
Press Release / Oct 03, 2024
Hovione and Zerion Pharma create joint venture to further expand use of Dispersome® technology
A partnership to accelerate the development of the Dispersome® technology platform and further expand its applicability and reach for increasing the solubility and bioavailability of small drug molecules.
Press Release / Sep 19, 2024
Hovione and iBET Announce the Establishment of ViSync® Technologies: A Venture in Cell and Gene Therapy Solutions
Commitment to partnership and joint innovation for cell and gene therapies
News / Sep 09, 2024
Hovione Commits to Science-Based Targets for Greenhouse Gas (GHG) Emissions
Hovione commitment to setting SBTs in line with the Paris Agreement